why choose us

First received: November 07, 2022

Clinical Trial: A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cardiac Edema (CHF)

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Doseranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Brief Summary: To investigate the dose response in respect of weight decrease following repeated oral administration of OPC-131461 at 1, 2, 5, and 10 mg or placebo in patients with CHF with volume overload despite having received diuretics other than vasopressin antagonists

Read more